Fecal Microbiota Transplantation for Radiation-Induced Proctopathy

Recruiting now · Phase 2

Conditions studied: Radiation Induced Proctitis

In brief

The goal of this single-arm trial is to learn if Fecal Microbiota Transplantation (FMT) works to treat hemorrhagic radiation-induced proctopathy. The main questions it aims to answer are: * Dose FMT alleviate the symptom of severe rectal bleeding? * Dose FMT improve the endoscopic findings of proctopathy? Participants will: * Take fecal microbiota capsules by 8 sessions over a 12-week period. * Visit the clinic once every 4 weeks for checkups and tests. * Keep a diary of their symptoms and the number of times they use other supportive care.

Key facts

Study ID
NCT06776029
Run by
Sixth Affiliated Hospital, Sun Yat-sen University
People needed
20
Starts
2025-02-01
Expected to finish
2026-06-30
Last updated by the study team
2025-03-10

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.